The Yin-Yang functions of macrophages in metabolic disorders

Abstract

Macrophages are widely distributed in various metabolic tissues/organs and play an essential role in the immune regulation of metabolic homeostasis. Macrophages have two major functions: adaptive defenses against invading pathogens by triggering inflammatory cytokine release and eliminating damaged/dead cells via phagocytosis to constrain inflammation. The pro-inflammatory role of macrophages in insulin resistance and related metabolic diseases is well established, but much less is known about the phagocytotic function of macrophages in metabolism. In this review, we review our current understanding of the ontogeny, tissue distribution, and polarization of macrophages in the context of metabolism. We also discuss the Yin-Yang functions of macrophages in the regulation of energy homeostasis. Third, we summarize the crosstalk between macrophages and gut microbiota. Lastly, we raise several important but remain to be addressed questions with respect to the mechanisms by which macrophages are involved in immune regulation of metabolism.

Keywords

macrophages / NAFLD / diabetes / thermogenesis / dysbiosis

References

[1] Buck MD, Sowell RT, Kaech SM, et al. Metabolic instruction of immunity. Cell 2017;169:570–86.

[2] Cinkajzlova A, Mraz M, Haluzik M. Adipose tissue immune cells in obesity, type 2 diabetes mellitus and cardiovascular diseases. J Endocrinol 2021;252:R1–R22.

[3] Lin SZ, Fan JG. Peripheral immune cells in NAFLD patients: a spyhole to disease progression. EBioMedicine 2022;75:103768.

[4] Cooper MD, Alder MN. The evolution of adaptive immune systems. Cell 2006;124:815–22.

[5] Hirano M, Das S, Guo P, et al. The evolution of adaptive immunity in vertebrates. Adv Immunol 2011;109:125–57.

[6] Gordon S. Phagocytosis: the legacy of metchnikoff. Cell 2016b;166:1065–8.

[7] Gordon S, Pluddemann A. Tissue macrophages: heterogeneity and functions. BMC Biol 2017;15:53.

[8] Caputa G, Castoldi A, Pearce EJ. Metabolic adaptations of tissue-resident immune cells. Nat Immunol 2019;20:793–801.

[9] Nobs SP, Kopf M. Tissue-resident macrophages: guardians of organ homeostasis. Trends Immunol 2021;42:495–507.

[10] van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968;128:415–35.

[11] Gomez Perdiguero E, Klapproth K, Schulz C, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 2015;518:547–51.

[12] Hashimoto D, Chow A, Noizat C, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013;38:792–804.

[13] Schulz C, Gomez Perdiguero E, Chorro L, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012;336:86–90.

[14] Watanabe S, Alexander M, Misharin AV, et al. The role of macrophages in the resolution of inflammation. J Clin Invest 2019;129:2619–28.

[15] Yona S, Kim KW, Wolf Y, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013;38:79–91.

[16] van de Laar L, Saelens W, De Prijck S, et al. Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages. Immunity 2016;44:755–68.

[17] Beattie L, Sawtell A, Mann J, et al. Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions. J Hepatol 2016;65:758–68.

[18] Tran S, Baba I, Poupel L, et al. Impaired kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis. Immunity 2020;53:627–40.e625.

[19] Seidman JS, Troutman TD, Sakai M, et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity 2020;52:1057–74.e7 e1057.

[20] Scott CL, Zheng F, De Baetselier P, et al. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun 2016;7:10321.

[21] Cox N, Geissmann F. Macrophage ontogeny in the control of adipose tissue biology. Curr Opin Immunol 2020;62:1–8.

[22] Hassnain Waqas SF, Noble A, Hoang AC, et al. Adipose tissue macrophages develop from bone marrow-independent progenitors in Xenopus laevis and mouse. J Leukoc Biol 2017;102:845–55.

[23] Wang J, Chen WD, Wang YD. The relationship between gut microbiota and inflammatory diseases: the role of macrophages. Front Microbiol 2020;11:1065.

[24] Bain CC, Bravo-Blas A, Scott CL, et al. Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat Immunol 2014;15:929–37.

[25] De Schepper S, Verheijden S, Aguilera-Lizarraga J, et al. Self-maintaining gut macrophages are essential for intestinal homeostasis. Cell 2018;175:400–15 e413.

[26] Ide S, Yahara Y, Kobayashi Y, et al. Yolk-sac-derived macrophages progressively expand in the mouse kidney with age. Elife 2020;9:1.

[27] Shaw TN, Houston SA, Wemyss K, et al. Tissue-resident macrophages in the intestine are long lived and defined by Tim-4 and CD4 expression. J Exp Med 2018;215:1507–18.

[28] Mills CD, Kincaid K, Alt JM, et al. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000;164:6166–73.

[29] Belizario JE, Faintuch J, Garay-Malpartida M. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators Inflamm 2018;2018:2037838.

[30] Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol 2014;5:514.

[31] Arora S, Dev K, Agarwal B, et al. Macrophages: their role, activation and polarization in pulmonary diseases. Immunobiology 2018;223:383–96.

[32] Chu F, Shi M, Zheng C, et al. The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 2018;318:1–7.

[33] Orecchioni M, Ghosheh Y, Pramod AB, et al. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol 2019;10:1084.

[34] Trombetta AC, Soldano S, Contini P, et al. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. Respir Res 2018;19:186.

[35] Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. J Leukoc Biol 2013;93:875–81.

[36] Jaggi U, Yang M, Matundan HH, et al. Increased phagocytosis in the presence of enhanced M2-like macrophage responses correlates with increased primary and latent HSV-1 infection. PLoS Pathog 2020;16:e1008971.

[37] McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity 2014;41:36–48.

[38] Sheka AC, Adeyi O, Thompson J, et al. Nonalcoholic steatohepatitis: a review. JAMA 2020;323:1175–83.

[39] Geeraerts X, Bolli E, Fendt SM, et al. Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity. Front Immunol 2017;8:289.

[40] Kim KW, Zhang N, Choi K, et al. Homegrown macrophages. Immunity 2016;45:468–70.

[41] Artyomov MN, Sergushichev A, Schilling JD. Integrating immunometabolism and macrophage diversity. Semin Immunol 2016;28:417–24.

[42] Strelko CL, Lu W, Dufort FJ, et al. Itaconic acid is a mammalian metabolite induced during macrophage activation. J Am Chem Soc 2011;133:16386–9.

[43] Chen LL, Morcelle C, Cheng ZL, et al. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses. Nat Cell Biol 2022b;24:353–63.

[44] He W, Henne A, Lauterbach M, et al. Mesaconate is synthesized from itaconate and exerts immunomodulatory effects in macrophages. Nat Metab 2022;4:524–33.

[45] Chen F, Elgaher WAM, winterhoff M, et al. Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism. Nat Metab 2022a;4:534–46.

[46] Hruby A, Hu FB. The epidemiology of obesity: a big picture. PharmacoEcon 2015;33:673–89.

[47] Boutens L, Stienstra R. Adipose tissue macrophages: going off track during obesity. Diabetologia 2016;59:879–94.

[48] Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796–808.

[49] Harman-Boehm I, Bluher M, Redel H, et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007;92:2240–7.

[50] Smith U, Kahn BB. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids. J Intern Med 2016;280:465–75.

[51] Saito M, Matsushita M, Yoneshiro T, et al. Brown adipose tissue, diet-induced thermogenesis, and thermogenic food ingredients: from mice to men. Front Endocrinol (Lausanne) 2020;11:222.

[52] Qiu Y, Shan B, Yang L, et al. Adipose tissue macrophage in immune regulation of metabolism. Sci China Life Sci 2016;59:1232–40.

[53] Rahman MS, Jun H. The adipose tissue macrophages central to adaptive thermoregulation. Front Immunol 2022;13:884126.

[54] Russo L, Lumeng CN. Properties and functions of adipose tissue macrophages in obesity. Immunology 2018;155:407–17.

[55] Sakamoto T, Nitta T, Maruno K, et al. Macrophage infiltration into obese adipose tissues suppresses the induction of UCP1 level in mice. Am J Physiol Endocrinol Metab 2016;310:E676–87.

[56] Chung KJ, Chatzigeorgiou A, Economopoulou M, et al. A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity. Nat Immunol 2017;18:654–64.

[57] Crespo M, Nikolic I, Mora A, et al. Myeloid p38 activation maintains macrophage-liver crosstalk and BAT thermogenesis through IL-12-FGF21 axis. Hepatology 2022.

[58] Rao RR, Long JZ, White JP, et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 2014;157:1279–91.

[59] Henriques F, Bedard AH, Guilherme A, et al. Single-cell RNA profiling reveals adipocyte to macrophage signaling sufficient to enhance thermogenesis. Cell Rep 2020;32:107998.

[60] Nguyen KD, Qiu Y, Cui X, et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011;480:104–8.

[61] Qiu Y, Nguyen KD, Odegaard JI, et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014;157:1292–308.

[62] Fischer K, Ruiz HH, Jhun K, et al. Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis. Nat Med 2017;23:623–30.

[63] Brestoff JR, Kim BS, Saenz SA, et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015;519:242–6.

[64] Wang YN, Tang Y, He Z, et al. Slit3 secreted from M2-like macrophages increases sympathetic activity and thermogenesis in adipose tissue. Nat Metab 2021;3:1536–51.

[65] Jun H, Yu H, Gong J, et al. An immune-beige adipocyte communication via nicotinic acetylcholine receptor signaling. Nat Med 2018;24:814–22.

[66] Meng, W, Xiao T, Liang X, et al. The miR-182-5p/FGF21/acetylcholine axis mediates the crosstalk between adipocytes and macrophages to promote beige fat thermogenesis. JCI Insight 2021;6:e150249.

[67] Ruiz de Azua I, Mancini G, Srivastava RK, et al. Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages. J Clin Invest 2017;127:4148–62.

[68] Li L, Ma L, Zhao Z, et al. IL-25-induced shifts in macrophage polarization promote development of beige fat and improve metabolic homeostasis in mice. PLoS Biol 2021;19:e3001348.

[69] Pirzgalska RM, Seixas E, Seidman JS, et al. Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine. Nat Med 2017;23:1309–18.

[70] Chakarov S, Bleriot C, Ginhoux F. Role of adipose tissue macrophages in obesity-related disorders. J Exp Med 2022;219:1.

[71] Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87–91.

[72] Rohm TV, Meier DT, Olefsky JM, et al. Inflammation in obesity, diabetes, and related disorders. Immunity 2022b;55:31–55.

[73] Castoldi A, Naffah de Souza C, Camara NO, et al. The macrophage switch in obesity development. Front Immunol 2015;6:637.

[74] Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007a;117:175–84.

[75] Lumeng CN, Deyoung SM, Bodzin JL, et al. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007b;56:16–23.

[76] Chawla A, Nguyen KD, Goh YP. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 2011;11:738–49.

[77] Zhu L, Yang T, Li L, et al. TSC1 controls macrophage polarization to prevent inflammatory disease. Nat Commun 2014;5:4696.

[78] Byles V, Covarrubias AJ, Ben-Sahra I, et al. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun 2013;4:2834.

[79] Jiang H, Westerterp M, Wang C, et al. Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice. Diabetologia 2014;57:2393–404.

[80] Suzuki T, Gao J, Ishigaki Y, et al. ER stress protein CHOP mediates insulin resistance by modulating adipose tissue macrophage polarity. Cell Rep 2017;18:2045–57.

[81] Shan B, Wang X, Wu Y, et al. The metabolic ER stress sensor IRE1alpha suppresses alternative activation of macrophages and impairs energy expenditure in obesity. Nat Immunol 2017;18:519–29.

[82] Ying W, Fu W, Lee YS, et al. The role of macrophages in obesity-associated islet inflammation and beta-cell abnormalities. Nat Rev Endocrinol 2020;16:81–90.

[83] Zinselmeyer BH, Vomund AN, Saunders BT, et al. The resident macrophages in murine pancreatic islets are constantly probing their local environment, capturing beta cell granules and blood particles. Diabetologia 2018;61:1374–83.

[84] Dalmas E, Lehmann FM, Dror E, et al. Interleukin-33-activated islet-resident innate lymphoid cells promote insulin secretion through myeloid cell retinoic acid production. Immunity 2017;47:928–42.e7 e927.

[85] Orliaguet L, Dalmas E, Drareni K, et al. Mechanisms of macrophage polarization in insulin signaling and sensitivity. Front Endocrinol (Lausanne) 2020;11:62.

[86] Yin Y, Hao H, Cheng Y, et al. Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice. Cell Death Dis 2018;9:760.

[87] Chittezhath M, Gunaseelan D, Zheng X, et al. Islet macrophages are associated with islet vascular remodeling and compensatory hyperinsulinemia during diabetes. Am J Physiol Endocrinol Metab 2019;317:E1108–20.

[88] Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol 2022;22:429–43.

[89] Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015;148:547–55.

[90] Kazankov K, Jorgensen SMD, Thomsen KL, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol 2019;16:145–59.

[91] Xu HE, Guo JS. All about NASH: disease biology, targets, and opportunities on the road to NASH drugs. Acta Pharmacol Sin 2022;43:1101–2.

[92] Parthasarathy G, Revelo X, Malhi H. Pathogenesis of nonalcoholic steatohepatitis: an overview. Hepatol Commun 2020;4:478–92.

[93] Guillot A, Tacke F. Liver macrophages: old dogmas and new insights. Hepatol Commun 2019;3:730–43.

[94] Reid DT, Reyes JL, McDonald BA, et al. Kupffer cells undergo fundamental changes during the development of experimental NASH and are critical in initiating liver damage and inflammation. PLoS One 2016;11:e0159524.

[95] Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest 2017;127:55–64.

[96] Huang W, Metlakunta A, Dedousis N, et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 2010;59:347–357.

[97] An P, Wei LL, Zhao S, et al. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nat Commun 2020;11:2362.

[98] Arrese M, Cabrera D, Kalergis AM, et al. Innate immunity and inflammation in NAFLD/NASH. Dig Dis Sci 2016;61:1294–303.

[99] Krysko DV, Agostinis P, Krysko O, et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011;32:157–64.

[100] Mihm S. Danger-associated molecular patterns (DAMPs): molecular triggers for sterile inflammation in the liver. Int J Mol Sci 2018;19:1.

[101] Idrissova L, Malhi H, Werneburg NW, et al. TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess. J Hepatol 2015;62:1156–63.

[102] Soltis AR, Kennedy NJ, Xin X, et al. Hepatic dysfunction caused by consumption of a high-fat diet. Cell Rep 2017;21:3317–28.

[103] Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 2018;25:486–541.

[104] Gautheron J, Vucur M, Luedde T. Necroptosis in nonalcoholic steatohepatitis. Cell Mol Gastroenterol Hepatol 2015;1:264–5.

[105] Xu B, Jiang M, Chu Y, et al. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J Hepatol 2018;68:773–82.

[106] Chen S, Zhu JY, Zang X, et al. The emerging role of ferroptosis in liver diseases. Front Cell Dev Biol 2021;9:801365.

[107] Qi J, Kim JW, Zhou Z, et al. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice. Am J Pathol 2020;190:68–81.

[108] Tsurusaki S, Tsuchiya Y, Koumura T, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis 2019;10:449.

[109] Schwabe RF, Luedde T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol 2018;15:738–52.

[110] Shojaie L, Iorga A, Dara L. Cell death in liver diseases: a review. Int J Mol Sci 2020;21:1.

[111] Wan J, Weiss E, Ben Mkaddem S, et al. LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling. Sci Transl Med 2020;12:1.

[112] Gordon S. Phagocytosis: an immunobiologic process. Immunity 2016a;44:463–75.

[113] Varol C, Mildner A, Jung S. Macrophages: development and tissue specialization. Annu Rev Immunol 2015;33:643–75.

[114] Inoue Y, Fukui H, Xu X, et al. Colonic M1 macrophage is associated with the prolongation of gastrointestinal motility and obesity in mice treated with vancomycin. Mol Med Rep 2019;19:2591–8.

[115] Srivastava A, Chau K, Kwon H, et al. Early and frequent exposure to antibiotics in children and the risk of obesity: systematic review and meta-analysis of observational studies. F1000Res 2020;9:711.

[116] Vallianou N, Dalamaga M, Stratigou T, et al. Do antibiotics cause obesity through long-term alterations in the gut microbiome? A review of current evidence. Curr Obes Rep 2021;10:244–62.

[117] Scott NA, Andrusaite A, Andersen P, et al. Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis. Sci Transl Med 2018;10:1.

[118] Rohm TV, Fuchs R, Muller RL, et al. Obesity in humans is characterized by gut inflammation as shown by pro-inflammatory intestinal macrophage accumulation. Front Immunol 2021;12:668654.

[119] Biswas SK, Bonecchi R. Colonic macrophages “remote control” adipose tissue inflammation and insulin resistance. Cell Metab 2016;24:196–8.

[120] Rohm TV, Keller L, Bosch AJT, et al. Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity. Commun Biol 2022a;5:370.

[121] Scheithauer TPM, Rampanelli E, Nieuwdorp M, et al. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol 2020;11:571731.

[122] Winer DA, Winer S, Dranse HJ, et al. Immunologic impact of the intestine in metabolic disease. J Clin Invest 2017;127:33–42.

[123] Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol 2016;16:341–52.

[124] Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020;30:492–506.

[125] Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009;1:6–ra14.

[126] Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012;143:913–6 e917.

[127] Wu T, Li H, Su C, et al. Microbiota-derived short-chain fatty acids promote LAMTOR2-mediated immune responses in macrophages. mSystems 2020;5:e00587-20.

[128] Nakamura A, Kurihara S, Takahashi D, et al. Symbiotic polyamine metabolism regulates epithelial proliferation and macrophage differentiation in the colon. Nat Commun 2021;12:2105.

[129] Su CW, Chen CY, Li Y, et al. Helminth infection protects against high fat diet-induced obesity via induction of alternatively activated macrophages. Sci Rep 2018;8:4607.

[130] Rapin A, Chuat A, Lebon L, et al. Infection with a small intestinal helminth, Heligmosomoides polygyrus bakeri, consistently alters microbial communities throughout the murine small and large intestine. Int J Parasitol 2020;50:35–46.

[131] Walk ST, Blum AM, Ewing SA, et al. Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis 2010;16:1841–9.

[132] McCurdy CE, Bishop JM, Williams SM, et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009;119:323–35.

[133] Mouralidarane A, Soeda J, Visconti-Pugmire C, et al. Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. Hepatology 2013;58:128–38.

[134] Oben JA, Mouralidarane A, Samuelsson AM, et al. Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol 2010;52:913–20.

[135] Thorn SR, Baquero KC, Newsom SA, et al. Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates. Diabetes 2014;63:2702–13.

[136] Soderborg TK, Clark SE, Mulligan CE, et al. The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. Nat Commun 2018;9:4462.

[137] Mathieu M, Martin-Jaular L, Lavieu G, et al. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol 2019;21:9–17.

[138] Choi Y, Kwon Y, Kim DK, et al. Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle. Sci Rep 2015;5:15878.

[139] Luo Z, Ji Y, Gao H, et al. CRIg(+) macrophages prevent gut microbial DNA-containing extracellular vesicle-induced tissue inflammation and insulin resistance. Gastroenterology 2021;160:863–74.

[140] Bai J, Liu F. The cGAS-cGAMP-STING pathway: a molecular link between immunity and metabolism. Diabetes 2019;68:1099–108.

[141] Bai J, Liu F. cGASSTING signaling and function in metabolism and kidney diseases. J Mol Cell Biol 2021;13:728–38.

[142] Cai D, Gao W, Li Z, et al. Current development of nano-drug delivery to target macrophages. Biomedicines 2022;10:12031.

[143] Soares S, Sousa J, Pais A, et al. Nanomedicine: principles, properties, and regulatory issues. Front Chem 2018;6:360.

[144] Chen W, Schilperoort M, Cao Y, et al. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat Rev Cardiol 2022c;19:228–49.

[145] Lameijer MA, Tang J, Nahrendorf M, et al. Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease. Expert Rev Mol Diagn 2013;13:567–80.

RIGHTS & PERMISSIONS

The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.